person

Olov R.

Country
Sweden
Department
Backens Hälsocentral, Manusgränd 3, 901 24, Umeå

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 28 partner sites.

Specializations

Cardiovascular and Thromboembolic Therapy

Olov Rolandsson concentrates on therapeutic strategies for cardiac rhythm disorders, heart failure, coronary pathology, and anticoagulation management.

  • atrial fibrillation
  • heart failure with reduced ejection fraction
  • coronary artery disease
  • anticoagulation in chronic kidney disease
  • dual antiplatelet therapy after coronary bypass

Emphasis is placed on early interventional approaches and novel oral anticoagulants.

Amyloid and Neurologic Disorders

His work addresses hereditary transthyretin amyloidosis and progressive neurodegenerative conditions.

  • hereditary transthyretin amyloidosis with polyneuropathy
  • transthyretin amyloid cardiomyopathy
  • amyotrophic lateral sclerosis
  • mild cognitive impairment

Integrates cardiology and neurology perspectives to explore disease‑modifying interventions.

Oncology and Hematologic Malignancies

He participates in trials spanning solid tumors and blood cancers, evaluating targeted and immune‑based therapies.

  • advanced breast cancer
  • non‑small cell lung cancer
  • acute lymphoblastic leukaemia
  • chronic lymphocytic leukaemia
  • multiple myeloma

Focus includes novel agents, combination regimens, and maintenance strategies.

Metabolic and Endocrine Disorders

His investigations target diabetes, obesity, and associated metabolic complications.

  • type 2 diabetes
  • type 1 diabetes
  • obesity
  • metabolic syndrome

Studies often assess cardiovascular and renal outcomes within diabetic cohorts.

Pulmonary and Respiratory Diseases

He engages in research on chronic airway disorders and acute respiratory infections.

  • chronic obstructive pulmonary disease
  • moderate-to-severe asthma
  • pulmonary arterial hypertension
  • COVID‑19

Efforts include disease‑modifying treatments and supportive care strategies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.